Target intelligence / Profile preview

23S ribosomal RNA (23S rRNA) (23S rRNA)

Target
23S rRNA
Molecular classification
Ribozyme, Ribosomal RNA, Enzyme, Other
01

Overview

The 23S ribosomal RNA (23S rRNA) is the catalytic heart of the bacterial 50S ribosomal subunit, functioning as a ribozyme that facilitates peptide bond formation during protein synthesis (Moore & Steitz, 2002, Nature). It contains the peptidyl transferase center (PTC) and the nascent peptide exit tunnel (NPET), both of which are essential for translating genetic information into functional proteins (Wilson, 2014, Nature Reviews Microbiology). Due to its fundamental role in bacterial viability and its structural divergence from eukaryotic ribosomal RNA, it serves as a highly effective target for multiple classes of antibiotics (Dunkle et al., 2010, PNAS). Drugs such as macrolides, oxazolidinones, and lincosamides bind to specific pockets within the 23S rRNA to physically block the elongation of the protein chain or the movement of tRNA (Long & Vester, 2012, Antimicrobial Agents and Chemotherapy). Resistance to these drugs often involves modifications to the 23S rRNA, such as methylation by Erm enzymes or point mutations like A2058G, which hinder drug binding (StatPearls, 2023). Understanding the structural biology of the 23S rRNA remains crucial for developing next-generation antibiotics to combat multi-drug resistant bacterial strains.

Other names
23S rRNALarge subunit ribosomal RNALSU rRNAPeptidyl transferase center RNA50S ribosomal RNA
02

Mechanism of action

Antibiotics targeting the 23S rRNA typically bind to the peptidyl transferase center (PTC) or the nascent peptide exit tunnel (NPET) within the 50S ribosomal subunit. This binding physically obstructs the formation of peptide bonds or prevents the elongation of the nascent polypeptide chain, thereby inhibiting bacterial protein synthesis (Wilson, 2014, Nature Reviews Microbiology; Dunkle et al., 2010, PNAS).

03

Biological functions

Protein synthesisTranslationPeptidyl transferase activityRibosome assembly
04

Disease associations

Infection
05

Safety considerations

Antibiotic resistanceMitochondrial protein synthesis inhibitionMyelosuppressionGastrointestinal dysbiosis
06

Interacting drugs

Erythromycin

10 more in the full profile.

07

Biomarkers

23S rRNA A2058G mutation23S rRNA A2059G mutationerm gene methylationcfr gene methylation

Beyond the preview

Go deeper on 23S ribosomal RNA (23S rRNA) (23S rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 23S ribosomal RNA (23S rRNA) (23S rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call